About
What we do
Staff
Executive Committee
MDD Scientific Advisory Board
Affiliates
Campus Partners
Resources
Drug Discovery Roadmap
Drug Discovery Research Cores
Our Funding Opportunities
U-M Funding Opportunities
Consulting Services
External Resources
Internal Resources
External Partners
Highlighted Projects
Recent News
Contact Us
Support Us
Select Page
Milken Institute: COVID-19 Treatment and Vaccine Tracker
Mar 23, 2020
Search for:
Recent Posts
Join us on Wednesday, September 30th, 2026 for the 6th Annual Drug Discovery Symposium!
Leukemia treatment based on U-M research gets FDA approval
Courage Therapeutics receives $7.8M investment to advance weight regulation drugs
Integrated stress response plasticity governs normal cell adaptation to chronic stress via the PP2A-TFE3-ATF4 pathway
A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance